{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:53:16Z","timestamp":1787014396439,"version":"build-2736575974"},"reference-count":13,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2004,10,22]],"date-time":"2004-10-22T00:00:00Z","timestamp":1098403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2004,11]]},"abstract":"<jats:p>\n                    <jats:bold>BACKGROUND:\u2002<\/jats:bold>\n                    Concern about West Nile virus (WNV) transfusion\u2010transmitted infections missed by minipool (MP) nucleic acid testing (NAT) has prompted consideration of the use of individual\u2010donation (ID) NAT. Strategies were investigated for the application of limited ID\u2010NAT capacity in 2004.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>STUDY DESIGN AND METHODS:\u2002<\/jats:bold>\n                    Patterns of WNV MP\u2010NAT\u2010reactive donations tested by the Blood Systems Laboratory each week for 79 blood centers from June 29 to November 23, 2003 (196 MP\u2010NAT repeat\u2010reactive [RR] donations among 801,697 units), were analyzed. ID\u2010NAT initiation strategies were developed consisting of counts of RR donations and\/or weekly RR rates, together with three ID\u2010NAT discontinuation strategies, and ID testing burden was assessed based on these combined start and stop strategies.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>RESULTS:\u2002<\/jats:bold>\n                    The effectiveness, reported as the percentage of MP\u2010RR donations that would trigger ID\u2010NAT based on each initiation strategy, ranged from 57 to 100\u2003percent. The addition of a 1\u2010 or 2\u2010week no\u2010yield requirement for ID discontinuation substantially increased testing burden. Combined strategies resulted in projected ID\u2010NAT of between 10 and 50\u2003percent of donations for a 10\u2010 to 20\u2010week period. For this organization, the most feasible ID\u2010NAT initiation strategy was 2 MP\u2010reactive donations and a weekly rate of 1 in 1000, which had an effectiveness of 81\u2003percent and led to peak weekly ID\u2010NAT of 20 to 25\u2003percent of donations depending on the discontinuation rule.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>CONCLUSION:\u2002<\/jats:bold>\n                    This new approach of targeted ID\u2010NAT based on ongoing monitoring of MP\u2010NAT yield may prove to be a rational policy for agents like WNV that cause seasonal and regional epidemics.\n                  <\/jats:p>","DOI":"10.1111\/j.0041-1132.2004.04227.x","type":"journal-article","created":{"date-parts":[[2004,10,22]],"date-time":"2004-10-22T13:34:51Z","timestamp":1098452091000},"page":"1547-1554","source":"Crossref","is-referenced-by-count":56,"title":["Triggers for switching from minipool testing by nucleic acid technology to individual\u2010donation nucleic acid testing for West Nile virus: Analysis of 2003 data to inform 2004 decision making"],"prefix":"10.1111","volume":"44","author":[{"given":"Brian","family":"Custer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Tomasulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Caglioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Harpool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,10,22]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.3.293"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365540310016835"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030969"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022987"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp038138"},{"key":"e_1_2_6_7_2","volume-title":"Guidance for industry: revised recommendations for the assessment of donor suitability and blood and and blood product safety in cases of known or suspected West Nile virus infection [Internet].","year":"2004"},{"key":"e_1_2_6_8_2","volume-title":"Final guidance to blood industry on West Nile virus [Internet].","year":"2004"},{"key":"e_1_2_6_9_2","first-page":"281","article-title":"Update: West Nile virus screening of blood donations and transfusion\u2010associated transmission\u2014United States, 2003","volume":"53","author":"Centers for Disease Control and Prevention (CDC).","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20031223"},{"issue":"11","key":"e_1_2_6_11_2","first-page":"57a","article-title":"Yield of West Nile virus RNA screening of U.S. blood donors. Abstract 190 (oral) Presented at the 45th Annual Meeting of the American Society of Hematology; 2003 Dec; San Diego, CA","volume":"102","author":"Caglioti S","year":"2003","journal-title":"Blood"},{"key":"e_1_2_6_12_2","unstructured":"SazamaK Shoos LiptonK.Update on WNV\u2010related activities and considerations 2004: a summary of the WNV Task Force meeting.AABB Bull2004:2004."},{"key":"e_1_2_6_13_2","first-page":"769","article-title":"Detection of West Nile virus in blood donations\u2014United States, 2003","volume":"52","author":"Centers for Disease Control and Prevention (CDC).","year":"2003","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_6_14_2","unstructured":"CagliotiS McAuleyJ RobertsonGF et al.Relative yield of mini\u2010pool versus individual donation NAT for West Nile virus RNA.Transfusion 2004;44:6A."}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0041-1132.2004.04227.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0041-1132.2004.04227.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0041-1132.2004.04227.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T08:12:15Z","timestamp":1697271135000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0041-1132.2004.04227.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,22]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1111\/j.0041-1132.2004.04227.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0041-1132.2004.04227.x","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,22]]}}}